
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 57 | 65.99 | 66.64 | 35 |
| 242 | 65.98 | 66.65 | 160 |
| 50 | 65.95 | 66.80 | 15 |
| 32 | 65.72 | 66.85 | 10 |
| 100 | 65.70 | 67.30 | 82 |
| 3856 | Total | Total | 602 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 57 | 65.99 | 66.64 | 35 |
| 242 | 65.98 | 66.65 | 160 |
| 50 | 65.95 | 66.80 | 15 |
| 32 | 65.72 | 66.85 | 10 |
| 100 | 65.70 | 67.30 | 82 |
| 3856 | Total | Total | 602 |
| Open | 68.40 |
| Previous Close | 66.42 |
| Volume | 8,250.00 |
| Value (Lacs) | 5.48 |
| VWAP | 66.13 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 105 |
| High | 68.40 |
| Low | 64.95 |
| UC Limit | 79.70 |
| LC Limit | 53.13 |
| 52 Week High | 128.01 |
| 52 Week Low | 62.75 |
| Face Value | 10.00 |
| All Time High | 442.40 |
| All Time Low | 3.50 |
| 20D Avg Volume | 27,743 |
| 20D Avg Delivery(%) | 54.06 |
| Book Value Per Share | 93.48 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | -6.17 |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 0.72 (Low P/B) |
| Sector PE | 39.83 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
10 out of 17 years Mangalam Drugs & Organics has given negative returns in October.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| October | 41.38% (2015) | 12.51% | -12.55% (2024) | -5.20% | 2.09% |
Mangalam Drugs Standalone March 2025 Net Sales at Rs 73.04 crore, down 28.56% Y-o-Y May 19 2025 11:53 AM
Mangalam Drugs Consolidated December 2024 Net Sales at Rs 88.71 crore, down 8.86% Y-o-Y Mar 04 2025 12:11 PM
Mangalam Drugs Standalone September 2024 Net Sales at Rs 79.94 crore, down 1.98% Y-o-Y Nov 26 2024 10:14 AM
Mangalam Drugs clocks fresh 52-week high on securing grant to develop antimalarial drug Aug 26 2024 02:54 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Mangalam Drugs | 66.06 | -0.54 | 104.56 | - | 0.70 | 4.65 | -40.77 | 6 | 318 | 0.55 |
| Sun Pharma | 1,681.00 | -2.03 | 403,328.21 | 38.89 | 5.58 | 15.13 | -9.24 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,568.50 | 0.87 | 174,373.04 | 75.61 | 11.65 | 14.63 | 11.58 | 2,191 | 9,360 | 0.00 |
| Cipla | 1,562.60 | -1.17 | 126,221.47 | 23.41 | 4.45 | 16.90 | 10.18 | 5,291 | 27,547 | 0.00 |
| Torrent Pharma | 3,561.10 | -1.06 | 120,523.81 | 60.20 | 16.06 | 25.17 | 13.49 | 1,911 | 11,516 | 0.40 |